Synthesis and anti-HIV activity of 2-naphthyl substituted DAPY analogues as non-nucleoside reverse transcriptase inhibitors

被引：38
作者：
Liang, Yong-Hong [1 ]
He, Qiu-Qin [1 ]
Zeng, Zhao-Sen [1 ]
Liu, Zhi-Qian [1 ]
Feng, Xiao-Qing [1 ]
Chen, Fen-Er [1 ,2 ]
Balzarini, Jan [3 ]
Pannecouque, Christophe [3 ]
De Clercq, Erik [3 ]
机构：
[1] Fudan Univ, Dept Chem, Shanghai 200433, Peoples R China
[2] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China
[3] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium
来源：
BIOORGANIC & MEDICINAL CHEMISTRY | 2010年 / 18卷 / 13期
基金：
中国国家自然科学基金;
关键词：
HIV-1; Reverse transcriptase; NNRTIs; DAPY; DIARYLPYRIMIDINE ANALOGS; COLORIMETRIC ASSAY; ANTIVIRAL ACTIVITY; MUTANT STRAINS; WILD-TYPE;
D O I：
10.1016/j.bmc.2010.05.036
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Nine newly 6-cynao-2-naphthyl substituted diarylpyrimidines (DAPY) were synthesized as non-nucleoside reverse transcriptase inhibitors on the basis of our previous work. The antiviral and cytotoxicity evaluation indicated that these compounds displayed strong activity against wild-type HIV-1 at nanomolar concentrations with selectivity index SI greater than 23 779. The most active compounds 3c and 3e exhibited activity against the double mutant (103N+181C) strains at an EC50 of 0.16 and 0.15 mu M, and were more activity than that of efavirenz. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码：4601 / 4605
页数：5
相关论文
共 14 条
  • [1] The taming of capsaicin.: Reversal of the vanilloid activity of N-acylvanillamines by aromatic iodination
    Appendino, G
    Daddario, N
    Minassi, A
    Moriello, SM
    De Petrocellis, L
    Di Marzo, V
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (14) : 4663 - 4669
  • [2] Structural Modifications of DAPY Analogues with Potent Anti-HIV-1 Activity
    Feng, Xiao-Qing
    Liang, Yong-Hong
    Zeng, Zhao-Sen
    Chen, Fen-Er
    Balzarini, Jan
    Pannecouque, Christophe
    De Clercq, Erik
    [J]. CHEMMEDCHEM, 2009, 4 (02) : 219 - 224
  • [3] FRAUZEN H, 1921, J PRAKT CHEM, V103, P369
  • [4] Fries K, 1930, LIEBIGS ANN CHEM, V484, P245
  • [5] Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO
  • [6] 2-6
  • [7] Synthesis of novel diarylpyrimidine analogues and their antiviral activity against human immunodeficiency virus type 1
    Guillemont, J
    Pasquier, E
    Palandjian, P
    Vernier, D
    Gaurrand, S
    Lewi, PJ
    Heeres, J
    de Jonge, MR
    Koymans, LMH
    Daeyaert, FFD
    Vinkers, MH
    Arnold, E
    Das, K
    Pauwels, R
    Andries, K
    de Béthune, MP
    Bettens, E
    Hertogs, K
    Wigerinck, P
    Timmerman, P
    Janssen, PAJ
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (06) : 2072 - 2079
  • [8] Etravirine
    Haubrich, Richard
    Gubernick, Steven
    Yasothan, Uma
    Kirkpatrick, Peter
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (04) : 287 - 288
  • [9] Design, Synthesis, and SAR of Naphthyl-Substituted Diarylpyrimidines as Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase
    Liang, Yong-Hong
    Feng, Xiao-Qing
    Zeng, Zhao-Sen
    Chen, Fen-Er
    Balzarini, Jan
    Pannecouque, Christophe
    De Clercq, Erik
    [J]. CHEMMEDCHEM, 2009, 4 (09) : 1537 - 1545
  • [10] QSAR studies for diarylpyrimidines against HIV-1 reverse transcriptase wild-type and mutant strains
    Liang, Yong-Hong
    Chen, Fen-Er
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (02) : 625 - 631
12